Infectious Pericarditis

Öz

Sıklıkla kendi kendini sınırlayabilen, nedeni belli olmayan ve enfeksiyöz nedenlerin etyolojide önde geldiği perikardit hastalığında nadir durumlarda ölüm görülebilir. Miyokardı çevreleyen ince zar özellikle viral organizmalar tarafından enfekte olmaktadır. Burada, yakın zamanda yayınlanan Türk ve dünya literatürüne göz atılacak ve Epstein Barr virüs, H1N1 virüs ve tüberküloz gibi perikardite ve hatta tamponada neden olabilen mikroorganizmalar tartışılacaktır. Enfeksiyon kaynağı olarak perikardiyal efüzyon, konstriktif ve kristal perikarditleri ile karşımıza çıkan nadir parazit enfestasyonlarını da keza bulabilecek ve miksödem ve üremi gibi metabolik olaylarlarla nadiren olan birlikteliklerini okuyacaksınız

Anahtar Kelimeler

• Perikardit, enfeksiyöz perikardit, enfeksiyon

Infectious Pericarditis

Öz

Mostly self-limited with an idiopathic or infectious etiology, pericarditis may be fatal in rare occasions. Thiny layer surrounding myocardium is infected especially by viral organisms. Here, a recent Turkish and world literature will be reviewed and cases of Epstein Barr virus, H1N1 virus as well as tuberculosis microorganisms leading to pericarditis and even tamponade will be discussed. You will also find rare parasitic infestations presenting with pericardial effusion, constrictive and crystal pericarditis of infectious origin and read other rare metabolic associations such as myxedema and uremia

Anahtar Kelimeler

• Pericarditis, infectious pericarditis, infection

Kaynakça

1. Ball JB, Morrison WL. Cardiac tamponade. Postgrad Med J 1997;73(857):141-5.
2. Bishop LH, Estes EH, McIntosh HD. The electrocardiogram as a safeguard in pericardiocentesis. J Am Med Assoc 1956 22;162(4):264-5.
3. Maggiolini S, Osculati G, Vitale G. Utility and safety of di- agnostic pericardiocentesis. Eur Heart J 2005;26(10):1046- 7.
4. Vayre F, Lardoux H, Pezzano M, Bourdarias JP, Dubourg O. Subxiphoid pericardiocentesis guided by contrast two- dimensional echocardiography in cardiac tamponade: ex- perience of 110 consecutive patients. Eur J Echocardiogr 2000;1(1):66-71.
5. Tsang TS, Enriquez-Sarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice pat- terns, and outcomes spanning 21 years. Mayo Clin Proc 2002;77(5):429-36.
6. Cikes I. A new millennium without blind pericardiocente- sis? Eur J Echocardiogr 2000;1(1):5-7.
7. Duvernoy O, Borowiec J, Helmius G, Erikson U. Complications of percutaneous pericardiocentesis under fluoroscopic guidance. Acta Radiol 1992;33(4):309-13.
8. Ozer HO, Davutoglu V, Cakici M, et al. Echocardiography- guided pericardiocentesis with the apical approach. Turk Kardiyol Dern Ars 2009;37(3):177-81.

9. Matthew P. Fronheiser and Stephen W. Smith M, IEEE. Analysis of a Vibrating Interventional Device to Improve 3-D Colormark Tracking. IEEE Transactions On Ultrasonics, Ferroelectrics, and Frequency Control 2007;54(8):1700-7.
10. Armstrong G, Cardon L, Vilkomerson D, et al. Localization of needle tip with color doppler during pericardiocente- sis: In vitro validation and initial clinical application. J Am Soc Echocardiogr 2001;14(1):29-37.
11. Fronheiser MP, Real-Time 3D Color Flow Doppler for Guidance of Vibrating Interventional Devices. Ultrasonic imaging 2004;26:71-84.
12. Klein SM, Fronheiser MP, Reach J, Nielsen KC, Smith SW. Piezoelectric vibrating needle and catheter for enhancing ultrasound-guided peripheral nerve blocks. Anesth Analg 2007;105(6):1858-60.
13. Klein SV, Afridi H, Agarwal D, Coughlin BF, Schielke LH. CT directed diagnostic and therapeutic pericardiocentesis: 8-year experience at a single institution. Emerg Radiol 2005;11(6):353-63. 5